Anixa Biosciences Inc — Director's Dealing 2012

Sep 28, 2012

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2012-09-19

Reporting Person: Roop John H. (Sr. Vice President-Engineering)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Options (Right to Buy)	$0.2175	2022-09-19	Common Stock (4000000)		Direct
Employee Stock Options (Right to Buy)	$0.2175	2022-09-19	Common Stock (4000000)		Direct

Footnotes

F1: The option vests in 36 equal monthly installments beginning on 10/31/2012.

F2: The option becomes exercisable, if at all, as follows: (i) 1,333,334 shares upon the achievement of certain performance criteria (ii) 2,666,666 shares in two equal installments if the average closing price of the Company's common stock exceeds certain specified levels.